enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Benign prostatic hyperplasia - Wikipedia

   en.wikipedia.org/wiki/Benign_prostatic_hyperplasia

   Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate gland. [1] Symptoms may include frequent urination , trouble starting to urinate, weak stream, inability to urinate , or loss of bladder control . [ 1 ]

3. Finasteride - Wikipedia

   en.wikipedia.org/wiki/Finasteride

   In males aged 55 years old and over finasteride decreases the risk of low-grade prostate cancer but may increase the risk of high-grade prostate cancer and has no effect on overall survival. [32] A 2010 review found a 25% reduction in the risk of prostate cancer with 5α-reductase inhibitor. [33]

4. Androgen replacement therapy - Wikipedia

   en.wikipedia.org/wiki/Androgen_replacement_therapy

   50–250 mg 1x/1–4 weeks Testosterone isobutyrate: Agovirin Depot: Aqueous suspension: 50–100 mg 1x/1–2 weeks Testosterone phenylacetate b: Perandren, Androject: Oil solution: 50–200 mg 1×/3–5 weeks Mixed testosterone esters: Sustanon 100, Sustanon 250: Oil solution: 50–250 mg 1×/2–4 weeks Testosterone undecanoate: Aveed, Nebido ...

5. How to Pay the Lowest Price for Cialis & Tadalafil - AOL

   www.aol.com/lifestyle/pay-lowest-price-cialis...

   Cialis varies significantly in price. Costs depend on your prescribed dosage and whether you go with brand-name Cialis or the more affordable generic version of tadalafil. Brand-name Cialis can be ...

6. Dutasteride - Wikipedia

   en.wikipedia.org/wiki/Dutasteride

   In a study of 6,729 men with benign prostatic hyperplasia (BPH, a condition where the prostate grows unassociated with cancer), 9% had erectile dysfunction (compared to 5.7% treated with a placebo), 3.3% experienced decreased sex drive (vs 1.6% of placebo), and 1.9% had enlarged breasts (vs 1% of placebo).

7. Prostate-specific antigen - Wikipedia

   en.wikipedia.org/wiki/Prostate-specific_antigen

   Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene.PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland in men and the paraurethral glands in women.